Equities

Shanghai Chicmax Cosmetic Co Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Shanghai Chicmax Cosmetic Co Ltd

Actions
Consumer DiscretionaryPersonal Goods
  • Price (HKD)56.25
  • Today's Change0.05 / 0.09%
  • Shares traded1.12m
  • 1 Year change+49.20%
  • Beta--
Data delayed at least 15 minutes, as of Mar 04 2026 08:08 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Shanghai Chicmax Cosmetic Co Ltd is a China-based company mainly engaged in the manufacturing and sale of cosmetic products. The Company mainly sells products under brands of KANS, One Leaf, Baby Elephant, and other brands. The Company distributes products through online channels and offline channels. The Company’s products are used for skin care, maternity and childcare, and others. The Company mainly operates its businesses in the domestic and overseas markets.

  • Revenue in HKD (TTM)8.41bn
  • Net income in HKD1.03bn
  • Incorporated2004
  • Employees2.46k
  • Location
    Shanghai Chicmax Cosmetic Co Ltd25 Floor, Building BNo. 3300 Zhongshan North Road, Putuo DisSHANGHAI ChinaCHN
  • Websitehttps://www.chicmaxgroup.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
PALTAC Corp60.75bn1.08bn14.99bn2.28k13.730.995410.700.2467355.75355.7519,935.134,907.792.3016.845.21537,743,700.004.114.387.207.717.537.621.781.841.43--0.0026.623.142.5710.79-2.09-37.948.45
Pola Orbis Holdings Inc8.43bn468.68m15.16bn4.02k31.271.8117.361.8042.7542.75768.73736.980.85521.939.78--4.765.105.505.8581.2081.975.566.033.37--0.0097111.05-0.0434-0.69312.0015.38-2.160.7875
Blue Moon Group Holdings Ltd8.46bn-520.90m15.25bn7.14k--1.96--1.80-0.0981-0.09811.591.330.85318.289.141,142,489.00-5.254.00-5.954.7960.4160.57-6.166.545.55--0.0108118.9716.823.95-330.34---5.31--
Shanghai Jahwa United Co Ltd6.97bn-667.88m15.89bn4.31k--1.99--2.28-0.8912-0.89129.2810.490.56793.627.891,429,630.00-5.442.10-7.412.8559.6557.80-9.583.581.57--0.082256.20-13.93-5.65-266.60---12.25-34.56
Emami Ltd3.24bn673.45m16.98bn3.22k25.21--20.585.2418.2018.2087.45--------11,866,520.00--22.86--30.8469.2365.9820.8120.43--54.49--50.896.467.4911.4621.63-22.4714.87
Softcare Ltd-100.00bn-100.00bn17.07bn--------------------------------------------------10.46--47.05------
Kose Holdings Corp16.34bn747.85m17.67bn8.13k22.261.1812.481.08264.83264.835,785.644,979.350.85041.436.26--4.14--5.33--69.04--4.87--2.47--0.0338--2.30--101.25------
Kobayashi Pharmaceutical Co Ltd8.20bn180.90m21.85bn3.62k115.051.9935.602.6649.1849.182,229.552,838.340.61313.453.27--1.355.691.697.1151.1154.432.218.932.10--0.003248.940.08581.95-63.68-28.2327.566.20
Shanghai Chicmax Cosmetic Co Ltd8.41bn1.03bn22.37bn2.46k21.778.1018.542.662.582.5821.126.931.992.8321.364,030,351.0025.5114.1641.2827.5274.7768.5012.799.411.46320.910.107236.0562.0818.7769.4265.688.01--
Gillette India Ltd2.61bn526.10m22.55bn513.0042.87--37.758.65190.41190.41943.65--------59,941,520.00--------63.06--20.18----67.39----------------
Lion Corp20.89bn1.37bn24.32bn7.65k17.631.519.421.1699.6899.681,525.161,166.550.8234.255.37--6.055.098.887.7345.9445.997.366.041.47--0.080734.132.223.5030.15-1.58-6.425.46
Proya Cosmetics Co Ltd12.34bn1.79bn30.43bn3.39k17.034.75--2.473.993.9927.5714.311.362.7336.893,214,578.0020.1617.4926.5923.6972.8968.1114.8313.512.69--0.135530.1721.0428.1130.0031.6312.8531.64
Procter & Gamble Hygiene & Health Care3.68bn728.74m30.88bn421.0042.37--40.578.39264.78264.781,337.25--------103,105,200.00--------63.07--19.80----92.83----------------
Data as of Mar 04 2026. Currency figures normalised to Shanghai Chicmax Cosmetic Co Ltd's reporting currency: Hong Kong Dollar HKD

Institutional shareholders

7.86%Per cent of shares held by top holders
HolderShares% Held
Aegon-Industrial Fund Management Co., Ltd.as of 30 Jun 20253.45m1.67%
The Vanguard Group, Inc.as of 04 Feb 20262.88m1.39%
China Universal Asset Management Co., Ltd.as of 30 Jun 20252.54m1.23%
China Asset Management Co., Ltd.as of 30 Jun 20251.39m0.68%
Zhong Ou Asset Management Co., Ltdas of 30 Jun 20251.23m0.60%
China Southern Asset Management Co., Ltd.as of 30 Jun 20251.21m0.59%
FIL Investment Management (Hong Kong) Ltd.as of 31 Dec 20251.15m0.56%
BlackRock Fund Advisorsas of 06 Feb 2026888.90k0.43%
Yinhua Fund Management Co., Ltd.as of 30 Jun 2025795.90k0.39%
Manulife TEDA Fund Management Co., Ltd.as of 30 Jun 2025674.34k0.33%
More ▼
Data from 30 Jun 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.